Share this @internewscast.com
As we enter the colder months in Australia, COVID-19 is making headlines again, this time due to the emergence of a new variant: NB.1.8.1.
Last week, the World Health Organization (WHO) designated NB.1.8.1 as a “variant under monitoring”, owing to its growing global spread and some notable characteristics which could set it apart from earlier variants.

So, what do you need to know about this new variant?

The current COVID-19 situation

More than five years since COVID-19 was initially declared a pandemic, we’re still experiencing regular waves of infections.

It’s more difficult to track the occurrence of the virus nowadays, as fewer people are testing and reporting infections. But available data suggests in late May 2025, case numbers in Australia were ticking upwards.

Genomic sequencing has confirmed NB.1.8.1 is among the circulating strains in Australia, and is generally increasing. Of cases sequenced up to 6 May across Australia, NB.1.8.1 ranged from less than 10 per cent in South Australia to more than 40 per cent in Victoria.
Wastewater surveillance in Western Australia has determined NB.1.8.1 is now the dominant variant in wastewater samples collected in Perth.
Internationally, NB.1.8.1 is also growing. By late April 2025, it comprised roughly 10.7 per cent of all submitted sequences — up from just 2.5 per cent four weeks before. While the absolute number of cases sequenced was still modest, this consistent upward trend has prompted closer monitoring by international public health agencies.

NB.1.8.1 has been spreading particularly in Asia — it was the dominant variant in Hong Kong and China at the end of April.

Where does this variant come from?

According to the WHO, NB.1.8.1 was first detected in samples collected in January 2025.

It’s a sublineage of the Omicron variant, descending from the recombinant XDV lineage. “Recombinant” is where a new variant arises from the genetic mixing of two or more existing variants.

What does the research say?

Like its predecessors, NB.1.8.1 carries a suite of mutations in the spike protein. This is the protein on the surface of the virus that allows it to infect us, specifically via the ACE2 receptors, a “doorway” to our cells.

The mutations include T22N, F59S, G184S, A435S, V445H, and T478I. It’s early days for this variant, so we don’t have much data on what these changes mean yet. But a recent preprint (a study that has not yet been peer-reviewed) offers some clues about why NB.1.8.1 may be gathering traction.

Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested — suggesting it may infect cells more efficiently than earlier strains.
The study also looked at how well antibodies from vaccinated or previously infected people could neutralise or “block” the variant. Results showed the neutralising response of antibodies was around 1.5 times lower against NB.1.8.1 compared to another recent variant, LP.8.1.1.

This means it’s possible a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants.

What are the symptoms?

The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. These factors could explain its rise in sequencing data.
But importantly, the WHO has not yet observed any evidence it causes more severe disease compared to other variants.
Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants.

Common symptoms include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases.

How about the vaccine?

There’s potential for this variant to play a significant role in Australia’s winter respiratory season. Public health responses remain focused on close monitoring, continued genomic sequencing, and promoting the uptake of updated COVID-19 boosters.
Even if neutralising antibody levels are modestly reduced against NB.1.8.1, the WHO has noted COVID-19 vaccines should still protect against severe disease with this variant.
The most recent booster available in Australia and many other countries targets JN.1, from which NB.1.8.1 is descended. So it makes sense that it should still offer good protection.
Ahead of winter and with a new variant on the scene, now may be a good time to consider another COVID-19 booster if you’re eligible. For some people, particularly those who are medically vulnerable, COVID-19 can still be a serious disease.
The Conversation Lara Herrero receives funding from the National Health and Medical Research Council.

Share this @internewscast.com
You May Also Like
Tania Henley

WA Woman Reflects on the Miracle of Comforting a Crying Backpacker

German backpacker Carolina Wilga’s astonishing tale of survival, stranded in the WA…

Air India Crash Investigation: Jet Engines Lost Fuel Supply Shortly Before Accident

In a tragic accident involving an Air India flight, which crashed soon…

Tour de France: Jonathan Milan Clinches Stage Eight Victory, While Australian Kaden Groves Falls Short

Jonathan Milan has won stage eight of the Tour de France in…

Man Accused of Attacking Woman with Axe and Running Her Over with Her Car

A man has been taken into custody following allegations of attacking a…
Thieves have stolen footage for an upcoming footy documentary from homegrown Hollywood star Eric Bana and former AFL player Koby Stevens in Melbourne.

“Disgusting Act: Ex-AFL Star Urges Thieves to Return Stolen Footage”

Koby Stevens and Australian Hollywood actor Eric Bana had dedicated five years…
Dementia is one of the leading causes of death in Australia but a new finding could revolutionise detection and treatment.

Breakthrough Discovery May Transform How We Detect and Treat Dementia

Dementia is one of the leading causes of death in Australia but…
Six men are on the run after brutally attacking a man with baseball bats near Campbelltown in Sydney's south-west.

Six Men Wanted Following Violent Baseball Bat Assault in Sydney

Six men are on the run after brutally attacking a man with…
Jaime Alanis, 57, is the first person to die in one of the Trump administration's anti-immigration operations. Yesenia Duran, Alanis' niece, confirmed his death to The Associated Press.

California Farmworker Dies After Falling from Roof During Disordered ICE Raid.

A farmworker who fell from a greenhouse roof during a chaotic ICE…

Anita Lester Reflects on Depicting Erin Patterson’s Distress

For most Australians, it’s an ordinary Monday. However, two hours away from…

Trump Accuses Reporter of Being ‘Very Evil’ Over Texas Flood System Inquiry

United States President Donald Trump has lashed out at a reporter during…

Millions of Australians Use This Common Medication, and Many Experience Odd Withdrawal Symptoms

Antidepressants rank among the most frequently prescribed medicines worldwide and in Australia,…

Several Palestinians killed in recent Israeli attacks on Gaza, more casualties found near aid station

Mahmoud Makram vividly recounts the moment gunfire erupted. This Palestinian man was…